Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does tolerance to cannabis’s benefits in sleep apnoea develop? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Some patients with obstructive sleep apnoea (OSA) explore cannabinoids to manage symptoms, but questions remain about cannabis tolerance in OSA. Over time, the body may adapt to cannabinoids, potentially leading to a reduced effect of cannabis on OSA. Understanding tolerance development is crucial for clinicians and patients considering long-term therapy. 

Am I eligible for medical cannabis for pain relief?

Monitoring Tolerance in Sleep Apnoea 

Before discussing strategies, it is important to note that cannabis tolerance in OSA varies between individuals. Careful observation and clinical assessment help determine whether efficacy changes over time. 

Gradual dose adjustments 

Clinicians may adjust cannabinoid doses if a reduced effect of cannabis on OSA is observed. Monitoring ensures patients receive symptom relief without unnecessary escalation. 

Periodic treatment breaks 

Planned breaks in therapy can help reset the body’s response. This approach may minimise cannabis tolerance in OSA while maintaining overall treatment effectiveness. 

Long-term outcome tracking 

Recording AHI, sleep quality, and daytime alertness over time is essential. Understanding tolerance development allows clinicians to balance benefits and minimise potential loss of efficacy. 

In summary, cannabis tolerance in OSA can occur, but careful monitoring, dosage management, and periodic reassessment can help maintain benefits and address any reduced effect of cannabis on OSA over the long term. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories